Expert Q&A: exploring the potential of 3D bioprinting
The fast-moving field of 3D bioprinting has the potential to revolutionise healthcare. The Engineer spoke to two engineers at the forefront of this exciting new technology frontier
Left: Chuck Hull - EVP, Chief Technology Officer for Regenerative Medicine, 3D Systems
Right: Felicity Rose - Professor of Biomaterials and Tissue Engineering, University of Nottingham
In general terms what is 3D bioprinting and how does it work?
FR: Bioprinting is defined as the application of 3D printing to biomedical applications. It involves the use of materials or ‘bioinks’ that include the cells found in our body. Using these bioinks, we can print 3D structures that recreate the tissues and organs found in our body. This process involves creating a design file that can be used by the printer to create the desired shape, developing a bioink that is suitable for the cells but also compatible with the bioprinting process, and isolated and expanding the cells of interest in the laboratory. Once printed, the bioink and the shape provide the necessary biochemical cues to the cells, during incubation, to support their growth and maturation into a functional tissue or organ.
Register now to continue reading
Thanks for visiting The Engineer. You’ve now reached your monthly limit of premium content. Register for free to unlock unlimited access to all of our premium content, as well as the latest technology news, industry opinion and special reports.
Benefits of registering
-
In-depth insights and coverage of key emerging trends
-
Unrestricted access to special reports throughout the year
-
Daily technology news delivered straight to your inbox
Experts speculate over cause of Iberian power outages
The EU and UK will be moving towards using Grid Forming inverters with Energy Storage that has an inherent ability to act as a source of Infinite...